Honors & Accreditations
The University of Chicago Medicine is fully accredited by the Joint Commission, the nation's leading organization for accreditation and certification of health care organizations.
» JCAHO Public Notice
In addition to achieving this standard, the University of Chicago has received special certifications from the Joint Commission for the following programs:
- Comprehensive Stroke Center Certification: The University of Chicago Medicine was the first Chicago hospital to be designated a Comprehensive Stroke Center, a level of certification reserved for institutions with specific abilities to receive and treat the most complex stroke cases. » Learn more about our stroke care.
- Ventricular Assist Device (VAD) Certification: The University of Chicago Medicine earned this special designation after undergoing a rigorous review process to help ensure that we provide high-quality, effective VAD care as a "destination therapy"--an alternative to heart transplant. » Learn more about our VAD care
The University of Chicago Comprehensive Cancer Center is one of only two National Cancer Institute (NCI)-designated Comprehensive Cancer Centers in Illinois. Here, more than 200 of the brightest minds in research are focused on cancer discoveries--working together to bring breakthroughs from the lab to the bedside as quickly as possible. We are one of the few programs in the country with NCI-sponsored programs for Phase-I, Phase-II, and Phase-III clinical trials of anti-cancer drugs.
Cellular Therapy Accreditation
We are the only medical center in Illinois to be accredited for all adult and pediatric cellular therapy services, as defined by the Foundation for the Accreditation of Cellular Therapy (FACT). These services include adult and pediatric autologous and allogeneic stem cell transplant therapy; bone marrow and apheresis collection; and processing services for the purposes of preparing cellular therapy products.
Accredited Cystic Fibrosis Centers
The Cystic Fibrosis Foundation has accredited both our adult and pediatric cystic fibrosis programs, which are staffed by physicians and nurses who specialize in the treatment of this chronic disease. The foundation funds accredited centers and performs yearly reviews to ensure each center provides the best possible care.
John A. Hartford Foundation Center of Excellence in Geriatric Medicine and Training
Our geriatrics program is one of a select group of such programs in the United States recognized by the John A. Hartford Foundation as a Center of Excellence in Geriatric Medicine and Training. This designation signifies that our geriatric medicine experts are actively training scientists and clinicians in the special knowledge and skills needed to ensure quality health care for older adults.
Blue Cross Blue Shield Blue Distinction
Blue Distinction® is a designation awarded by Blue Cross and Blue Shield companies to medical facilities that have demonstrated expertise in delivering quality health care. Facilities recognized for distinguished clinical care and processes are designated as Blue Distinction Centers for Specialty Care in seven key specialty areas. University of Chicago programs have earned Blue Distinction status in six categories, which include:
- Bariatric surgery
- Complex and rare cancers
- Knee and hip replacement
- Maternity Care
- Spine surgery
Designation as Blue Distinction Centers® means these facilities’ overall experience and aggregate data met objective criteria established in collaboration with expert clinicians’ and leading professional organizations’ recommendations. Individual outcomes may vary. To find out which services are covered by your policy at any facilities, please call your local Blue Cross and/or Blue Shield Plan.
U.S.News & World Report Rankings
In its annual survey, U.S. News & World Report consistently selects the University of Chicago Medicine as one of the best hospitals in the United States.
The University of Chicago Medicine ranks high in hospital safety according to The Leapfrog Group's national survey of more than 2,500 hospitals.
The University of Chicago Medicine is the largest Illinois recipient of research funding from the National Institutes of Health. This funding supports leading-edge clinical and basic science research in a wide variety of disciplines--from genetics and medicine to biodefense--and will help advance effective treatments for cancer, heart disease, pulmonary disease, and more. When comparing funding per scientific investigator in 2011, the University of Chicago ranks in the top three in the United States. As of November 2010, University of Chicago scientists were awarded more than $105 million in research funding from the American Recovery and Reinvestment Act (ARRA), the most awarded to any Illinois research institution. » View details about ARRA grant projects
Many groundbreaking firsts in medical care and research occurred at the University of Chicago. These include the following, and more:
- First successful living-donor liver transplant
- First sleep laboratory, and later the discovery of rapid eye movement (REM) sleep and its association with dreaming
- Discovery that helped demonstrate that cancer is a genetic disease
- Establishment of one of the nation's first premature infant nurseries